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Matrix Metalloproteinase 1 (MMP-1) is one of the proteases that degrade collagen type I, a major component
of bone ECM. In the present study, the biological relevance of MMP-1 in osteosarcoma (OS) tumor growth
and metastasis was investigated in vitro and in vivo. Human OS cells in primary culture expressed MMP-1
encoding mRNA at considerably higher levels than normal human bone cells. In addition, MMP-1 mRNA
and protein expression in the highly metastatic human osteosarcoma 143-B cell line was remarkably
higher than in the non-metastatic parental HOS cell line. Stable shRNA-mediated downregulation of
MMP-1 in 143-B cells impaired adhesion to collagen I and anchorage-independent growth, reﬂected
by a reduced ability to grow in soft agar. Upon intratibial injection into SCID mice, 143-B cells with
shRNA-downregulated MMP-1 expression formed smaller primary tumors and signiﬁcantly lower num-
bers of lung micro- and macrometastases than control cells. Conversely, HOS cells stably overexpressing
MMP-1 showed an enhanced adhesion capability to collagen I and accelerated anchorage-independent
growth compared to empty vector-transduced control cells. Furthermore, and most importantly, indivi-
dual MMP-1 overexpression in HOS cells enabled the formation of osteolytic primary tumors and lung
metastasis while the HOS control cells did not develop any tumors or metastases after intratibial injec-
tion. The ﬁndings of the present study reveal an important role of MMP-1 in OS primary tumor and
metastasis formation to the lung, the major organ of OS metastasis.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Osteosarcoma (OS) is a highly malignant bone tumor mainly affec-
ting children and young adults. Continuous progress in neo-adjuvant
chemotherapy increased the 5-year survival rate of patients over the
past 30 years from 20% to 70%. However, patients who present with
metastases at diagnosis, predominantly in the lung, continue to have a
poor 5-year survival rate of approximately 20% [1]. Consequently, the
identiﬁcation of novel targets for better diagnosis and more effective
treatment of OS patients with metastatic disease are of great importance.
Metastasis of primary tumor cells to distant organs is a complex,
multistage process that includes aberrantly regulated biological
events such as uncontrolled cell proliferation, tissue remodeling,
angiogenesis and invasion [2]. The colonization of tumor cells of
different cancer types in distant organs requires the expression of
distinct protein sets at variable time periods [3]. Proteolytic enzymes
including metallo-, serine-, aspartyl-, and cysteine proteases are
involved in different steps of metastasis [4,5]. These enzymes actc Research, Balgrist University
d. Tel.: +41 44 386 1665; fax:
rights reserved.either directly by degrading extracellular matrix (ECM) and cell
surface proteins, or indirectly through the activation of cascades of
proteolytic enzymes and the release of effector proteins associated
with the ECM [6].
The class of matrix metalloproteinases (MMPs) comprises more
than 20 extracellular zinc-dependent endopeptidases. The expression
of these proteins is regulated at the level of transcription and their
enzymatic activity by proteolytic activation and by selective inhibi-
tory proteins. Almost all components of the ECM and a wide variety
of non-matrix proteins are substrates of MMPs [7]. MMPs play an
important role in ECM remodeling in diverse physiological processes
including development, regeneration, and wound healing. They are
also involved in different pathological processes such as rheumatoid
arthritis, osteoarthritis, pulmonary emphysema, and cancer [8].
Matrix-metalloproteinase 1 (MMP-1), also known as collagenase-1,
is nondetectable in normal tissues, but its expression is rapidly induced
when tissue remodeling is needed. MMP-1 is able to cleave in vitro
several components of the ECM including the collagen types I, II, III,
VII, VIII and X aswell as laminin, tenascin, aggrecan, and serine protease
inhibitors [9]. In cancer, MMP-1 is expressed by tumor cells or by
surrounding stromal ﬁbroblasts at the site of invasion, indicating
the functional relevance of the protein in this process [10]. MMP-1
has been described as a prognostic marker for different types of
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chondrosarcoma, with an inverse correlation between survival and
MMP-1 expression [11–14]. Recently, Kang et al. [15] showed that
MMP-1—together with CXCR4 and IL-11—was highly overexpressed in
breast cancer cells that metastasized to bone and formed osteolytic
lesions in athymic nude mice.
Bone connective tissue has a functionally optimized composition.
Collagen is the main organic component of the ECM in normal bone
and consists predominantly of collagen type I. The protein is assem-
bled in insoluble ﬁbers that contribute to the structural integrity
and mechanical stability of bone. Only a few proteases, including
cathepsin K, MMP-1, -8, -13 and -14, are capable to cleave native
ﬁbrillar collagen type I [16]. The activity of one or several of these pro-
teases is a prerequisite for the degradation of bone ECM, which is
then completed by other proteases and allows primary tumor growth
and extravasation of tumor cells to distant organs.
Increased MMP-2 (gelatinase-A) and MMP-9 (gelatinase-B)
expression was identiﬁed as prognostic markers for poor outcome
of OS [17–19]. However, for MMP-8 (collagenase-2) and MMP-13
(collagenase-3) a correlation between protein expression in clinical
samples and patient survival was not observed [20], and, to our
knowledge, the relevance of MMP-1 for the outcome of OS has so
far not been investigated. In the present study, a comparison of
MMP-1 expression at the transcript level in cells of normal bone
and of OS cells in primary culture indicated an upregulation of
MMP-1 in all OS cell specimens collected from a series of primary
tumors. Based on these ﬁndings, we investigated the biological
relevance of MMP-1 for primary tumor growth and metastasis in
an intratibial human xenograft OS model in SCID mice. MMP-1 was
knocked-down in the highly metastatic human OS cell line 143-B
with robust endogenous MMP-1 expression and the proteinase was
overexpressed in the parental non-metastatic HOS cell line with
hardly detectable endogenous MMP-1. The results demonstrate an
important malignancy promoting role of MMP-1 in experimental
human OS.
2. Materials and methods
2.1. Cell lines and culture conditions
HOS, MNNG/HOS and HEK293-T cells were purchased from the
American Type Culture Collection (Rockville, MD) and 143-B cells
from the European Collection of Cell Cultures (Salisbury, UK). All
cell lines were grown in Dulbecco's modiﬁed Eagle medium (DMEM)
(4.5 g/L glucose) and Ham F12 (F12) medium (1:1) supplemented
with 10% fetal calf serum (FCS) (GIBCO, Basel, Switzerland) (cell culture
medium) in a humidiﬁed atmosphere of 95% air and 5% CO2 at 37 °C.
Normal human bone (NHB) and primary OS cells were isolated as
described [21] and grown in cell culture medium supplemented
with penicillin/streptomycin/amphotericin (PSA, 1:100, Invitrogen,
Carlsbad, CA). The tissue collection for generation of primary cells was
approved by the ethical committee of the Kanton of Zurich (reference
number EK-10-2007).
2.2. RNA isolation and RT-PCR
Total RNA was isolated from individual cell lines with TriReagent
(Sigma-Aldrich, St. Louis, MO) as described [22]. The RNA was
quantiﬁed by measuring the absorption at 260 and 280 nm in a
UV-spectrophotometer and RNA integrity was assessed by standard
agarose gel-electrophoresis. The expression of MMP-1, MMP-8 and
MMP-13 encoding mRNA was analyzed by reverse transcriptase
(RT)-PCR with GAPDH as a reference gene. cDNA was synthesized
from 1 μg of total RNA with the High Capacity cDNA Reverse Tran-
scription Kit (Applied Biosystems, Foster City, CA) and the protocol
recommended by the supplier. PCR reactions of 50 μl ﬁnal volumecontained 1× PCR buffer, 0.4 μl of the reverse transcription reaction,
1.25 U Taq polymerase (5Prime, Gaithersburg, MD), 200 μM of each
dNTP, and 0.2 μMof forward and reverse primer pairs speciﬁc for the
individual marker transcripts (GAPDH Forward: TGA ACG GGA AGC
TCA CTG GCA TGG; GAPDH Reverse: TGG GTG TCG CTG TTG AAG
TCA GAG GAG A; MMP-1 Forward: CTC GGC CAT TCT CTT GGA CTC
TCC CAT T, MMP-1 Reverse: AGC ATC AAA GGT TAG CTT ACT GTC
ACA CGC; MMP-8 Forward: CCT ATT TAA AGG CAA CCA ATA CTG
GGC TCT; MMP-8 Reverse: TTT GGG ATA ACC TGG CTC CAT GAA
TTG TCT; MMP-13 Forward: ATC CCT TGA TGC CAT TAC CAG TCT
CCG A; MMP-13 Reverse: AGA TGA AGA TGA GGT CAT GAG AAG
GGT GC). After initial denaturation at 94 °C for 3 min, DNA was
ampliﬁed by 27 to 40 PCR-cycles (denaturation at 94 °C for 40 s,
primer pair-dependent annealing at 67 °C to 69 °C for 40 s, and
elongation at 72 °C for 20 s) followed by a ﬁnal elongation step at
72 °C for 7 min. PCR products were analyzed by agarose gel (1.2%)
electrophoresis.
2.3. Real-time PCR analysis
The cDNAs from NHB cells (4 samples) and primary OS cells (eigh-
teen samples) were analyzed in triplicates using a Step One Plus
real-time PCR instrument (Applied Biosystems). 10 ng of cDNA, the
primer pairs described in the previous paragraph and the Power
SYBR® Green PCR master mix (Applied Biosystems) in a volume of
10 μl per reaction were used. GAPDH was chosen as a suitable
normalization control gene. Results were obtained by the compa-
rative Ct method [23], using ΔCt (the value for individual samples
was obtained by subtracting the Ct value of MMP-1 from the Ct
value of GAPDH). Primary OS cells with at least two-fold higher
MMP-1 mRNA expression than the normal human bone cells were
deﬁned as MMP-1 overexpressing cells.
2.4. Construction and generation of recombinant retrovirus
MMP-1 encoding cDNA was ampliﬁed by RT-PCR from total
RNA isolated from 143-B cells with the following primer pair:
Forward: TTG CAC TGA GAA AGA AGA CAA AGG and Reverse:
TGA GAA AAT AGA CAG TTC TTC AGG. The PCR product was cloned
into the pGEM®-T Easy Vector (Promega, Madison, WI) and the
sequence was veriﬁed by sequencing of both strands. The MMP-1
cDNA was then subcloned into the retroviral pQCXIN expression
vector (Clontech, Paolo Alto, CA).
shRNA (GAG CAA GAT GTG GAC TTA G) spanning nucleotides 153–
171 downstream of the transcription start site of MMP-1 mRNA have
previously been shown to efﬁciently downregulate the expression of
MMP-1 [24]. The scrambled shRNA, GAT TCA GGT GTA GAA CGA G
[24], with no signiﬁcant homology to any mammalian gene sequence
was used as non-silencing control. Pairs of complementary oligonu-
cleotides containing these sequences were synthesized (Mycrosynth,
Balgach, Switzerland) and cloned into the pSIREN-Retro Q retroviral
vector (Clontech). DNA sequences were veriﬁed by sequencing in
both directions.
Retroviral particles containing the described constructs were
produced in HEK293-T cells as described recently [25]. Brieﬂy,
HEK293-T cells were cultured in Advanced D-MEM medium (GIBCO)
supplemented with 2% fetal calf serum and a culture additive containing
0.01 mM cholesterol (Sigma), 0.01 mM egg's lecithin (Serva Electropho-
resis GmbH, Heidelberg, Germany) and 1× chemically deﬁned lipid con-
centrate (GIBCO) (transfection medium). The cells were co-transfected
using the calcium phosphate method with the following three plasmids:
the retroviral expression or shRNA vector together with the two helper
plasmids pVSV-G (Clontech), encoding the G-glycoprotein of the vesi-
cular stomatitis virus, and pHit60 coding for the retroviral gag and pol
genes (kindly provided by Dr. Christian Buchholz, Paul-Ehrlich-Institut,
Langen, Germany). Fourteen hours after transfection the medium was
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respective recombinant retrovirus was collected 48 h after transfection,
ﬁltered through a 0.45 μm syringe ﬁlter, aliquoted and stored at−80 °C.2.5. Generation of modiﬁed cell lines
HOS and 143-B OS cells were transduced with different viral
supernatants for 2 h in the presence of 8 μg/ml polybrene (Sigma-
Aldrich), and fresh cell culture medium was then added. HOS cells
transduced with the empty vector (pQCXIN) and the vector overex-
pressing MMP-1 were selected in cell culture medium containing
1200 μg/ml G-418 (Invitrogen). 143-B cells transduced with a non-
speciﬁc control shRNA (scrambled) or with the MMP-1 speciﬁc shRNA
(153–171) were selected with 5 μg/ml Puromycin (Invitrogen). In all
modiﬁed cell lines, MMP-1 protein expression was veriﬁed byWestern
blot analysis of cell supernatants.
In addition, all manipulated HOS and 143-B OS cell lines were
transduced with the lacZ gene in order to facilitate and improve
the identiﬁcation and localization of OS cells in mouse tissues as
described recently [25].
The manipulated cell lines were named HOS/LZ+EV (containing
the empty pQCXIN vector), HOS/LZ+MMP-1 (overexpressing MMP-1),
143-B/LZ+scr (containing the unspeciﬁc, control shRNA) and 143-B/
LZ+153 (containing the MMP-1 speciﬁc shRNA sequence). Authen-
tication of the cell lines was performed by multiplex PCR (Microsynth)
using the PowerPlex®16HS system (Promega) and veriﬁed by compari-
son with the database at the German Collection of Microorganisms and
Cell Cultures (DSMZ, Braunschweig, Germany).2.6. Western blot
Supernatants from cultures of equal numbers of cells of the indi-
vidual cell lines were collected 24 h after the last medium change
and centrifuged for 10 min at 500 ×g to remove cell debris. 30 μl
aliquots of collected cell supernatants were analyzed on Western
blots as described recently [22]. Membranes were probedwith a poly-
clonal rabbit antibody directed to MMP-1 (M4177, Sigma-Aldrich) at
a dilution of 1:1000. Bound antibodies were detected with a horse-
radish peroxidase conjugated goat anti-rabbit antiserum from
Santa Cruz Biotechnology (Santa Cruz, CA) at a dilution of 1:3000.
The peroxidase-conjugated antibody was visualized by chemilu-
minescence with the Immobilon chemiluminescence substrate
(Millipore, Billerica, MA) and the VersaDoc™ Imaging System
(Bio-Rad Laboratories, Hercules, CA).2.7. Adhesion assay
Wells of 96-well plates were coated for 1 h at room temperature
(RT) with 100 μl/well collagen type I (Becton & Dickenson, Franklin
Lakes, NJ) (1 μg/ml in water). They were then washed twice with
100 μl/well PBS, blocked with 100 μl/well 1% heat denatured BSA for
1 h at RT and washed once with 100 μl/well cell culture medium
before cell seeding. Single cell suspensions were prepared with
Accutase (Sigma-Aldrich). 5000 cells/well in 100 μl cell culture medi-
umwere plated and allowed to adhere to collagen type I for 15 min at
37 °C. Individual wells were washed once with 100 μl/well cell cul-
ture medium and with PBS and then ﬁxed with 100 μl/well 10% form-
aldehyde for at least 15 min at RT. Cells were stained with DAPI
and images were taken with a Nikon Eclipse E600 microscope
(Nikon Corporation, Tokyo, Japan). The numbers of bound cells
were quantiﬁed with the image processing program ImageJ [26].
The results are presented as the mean±SEM of four independent
experiments.2.8. Soft-agar colony formation assay
The experiments were carried out in six-well cell culture plates
containing 1.5 ml/well of 0.5% base agar in cell culture medium
supplemented with PSA. Single cell suspensions (20,000 cells per
well) of the individual cell lines prepared in 1.5 ml/well cell culture
medium containing 0.35% agar and PSA (top agar) were seeded on
the base agar and incubated in a humidiﬁed atmosphere of 95% air
and 5% CO2 at 37 °C. Twenty-four hours later the top agar was over-
laid with 2 ml/well cell culture medium containing PSA. Cells were
allowed to grow for 16 days and the medium was changed in 3 day
intervals. Colonies were stained with 0.005% crystal violet. Images
were taken with a Nikon Eclipse E600 microscope and the numbers
of colonies larger than 200 μm2 were counted with the image pro-
cessing program ImageJ [26]. The results are presented as the
mean±SEM of four independent experiments.
2.9. In vivo experiments
Female 6–7 week old immunosuppressed SCID mice were pur-
chased from Charles River Laboratories (Sulzfeld, Germany) and
kept in individually ventilated cages (IVC). Housing and experimental
protocols were in accordance with the Swiss Animal Protection Law
and in compliance with the regulations of the Veterinäramt, Kanton
Zurich. All manipulations were done under sterile conditions in a
laminar ﬂow hood.
All cell lines were grown to subconﬂuency, detached with Trypsin/
EDTA/PBS and prepared as single cell suspension in PBS/0.05% EDTA
at a density of 5×107cells/ml. Ten microliters of the cell suspension
containing 5×105 cells were orthotopically injected into the medullar
cavity of the left proximal tibia of the mice. The injection was
performed with a Hamilton syringe through an opening of the tibia
plateau pre-made with a 26-gauge needle. Tumor growth and
osteolysis were monitored by X-ray analysis once a week with the
Faxitron® MX-20 Specimen Radiography System (Faxitron X-Ray
LLC, Lincolnshire, IL). The tumor volume (V) was calculated from
the measurement of two perpendicular diameters using a caliper
rule, according to the following formula: V=0.5×L×(S)2 (L and S
are, respectively, the largest and smallest perpendicular tumor
diameters), Tumor volume=Volume of injected leg−Volume of
control leg. Organs and legs of the mice were prepared at sacri-
ﬁce and stained with 5-bromo-4-chloro-3-indolyl-β-D-galactoside
(X-gal) as described recently [25]. For quantiﬁcation of macro-
and micrometastases, images of the surface of one lung lobe of
individual mice were taken under a Nikon Eclipse E600 micro-
scope with a Kappa PS 20 C digital camera (Kappa optronics
GmbH, Gleichen, Germany) and imported as TIF ﬁles into Power
Point© software. Indigo-blue stained foci on lung surfaces with a
diameter >0.1 mm were deﬁned as macrometastases and foci with
a diameter b0.1 mm as micrometastases. The results are presented
as the mean±SEM number respective metastases counted in at
least ﬁve mice injected with indicated cell lines.
2.10. Statistical analyses
Experimental data sets were analyzed with the two-tailed
Student's t test using the GraphPad Prism5 software (La Jolla, CA). P
valuesb0.05 were considered as signiﬁcant.
3. Results
3.1. MMP-1 expression in primary OS cells and OS cell lines
The expression of MMP-1 at the transcript level was analyzed by
real-time PCR in primary human OS cells and compared to the
expression in normal human bone cells. In the group of primary
MMP-1
MMP-8
MMP-13
GAPDH
A
350 K. Husmann et al. / Biochimica et Biophysica Acta 1832 (2013) 347–354cells from patients who are dead (Ø 23 months after diagnosis), we
detected in six out of nine samples a >2 fold higher MMP-1 expres-
sion than in NHB cells (Table 1). In the second group of primary
cells from patients still alive (Ø 42 months after diagnosis), only
two of nine samples showed a >2 fold higher MMP-1 expression
than in NHB cells (Table 1).
MMP-1 expression was further analyzed in the established HOS
human OS cell line [27] and two sublines thereof, the chemically mu-
tated MNNG/HOS cells and the highly metastatic Ki-ras transformed
143-B cells [28,29]. MMP-1 was found upregulated at the mRNA
and at the protein levels in 143-B compared to HOS and MNNG/HOS
cells (Fig. 1A,B). In addition to MMP-1, MMP-8 and MMP-13 are
secreted proteinases, which are able to cleave native ﬁbrillar colla-
gens of types I, II, III, V and IX [9]. Therefore, we also investigated
the expression and a potential regulation of MMP-8 and MMP-13 in
these cell lines. MMP-8 transcripts were nondetectable in all three
OS cell lines and the levels of MMP-13 encoding mRNA were compa-
rable in the parental HOS cells and in the highly metastatic 143-B cells
(Fig. 1A).B
MMP-1
70-
55
35-
40-
kDa
C
MMP-1
70-
55-
35-
40-
kDa
Fig. 1. MMP-1 expression in human OS cells. (A) Expression of MMP-1, MMP-8,
MMP-13 and GAPDH encoding mRNAs in HOS, MNNG/HOS and 143-B cells.
(B) MMP-1 protein in supernatants of HOS, MNNG/HOS and 143-B cells and
(C) of MMP-1 expression-manipulated HOS/LZ and 143-B/LZ cells. mRNA levels in3.2. MMP-1 promotes cell adhesion and anchorage independent colony
formation in soft agar
The functional relevance of MMP-1 in OS in vitro and in vivo
was analyzed in lacZ-tagged HOS cells overexpressing MMP-1
(HOS/LZ+MMP-1) and in lacZ-tagged 143-B cells with shRNA
down-regulated MMP-1 expression (143-B/LZ+153). MMP-1 pro-
tein expression in the generated cell lines was veriﬁed by Western
blotting of cell supernatants and compared with the corresponding
HOS/LZ+EV (containing the empty vector) and 143-B/LZ+scr
(expressing non-speciﬁc shRNA) control cells. 143-B/LZ+153 cells
showed effective suppression of MMP-1 expression when com-
pared to the 143-B/LZ+scr control cells (Fig. 1C). MMP-1 was
nondetectable in supernatants of HOS/LZ+EV cells, whereas in
HOS/LZ+MMP-1 cells the protein was detected at the expected
molecular weight of 52 kDa (Fig. 1C).
Potential effects of up- or downregulated MMP-1 expression were
ﬁrst analyzed in vitro in a cell adhesion assay with collagen type I as sub-
strate. Downregulation of MMP-1 expression in 143-B/LZ+153 cells
reduced the percentage of adhering cells signiﬁcantly (P valueb0.05) by
more than 40% when compared to control 143-B/LZ+scr cells (Fig. 2A,
B). The number of adhering HOS/LZ+MMP-1 cells, on the other hand,
was more than two times higher than that of HOS/LZ+EV control cells
(Fig. 2A,B).
Anchorage independent growth, another important in vitro indi-
cator of malignant properties of cell lines, was investigated in a soft
agar assay. Downregulation of MMP-1 in 143-B/LZ+153 cells resulted
in reduced anchorage independent growth. The number of large colo-
nies (area>200 μm2) was reduced by more than 60% compared to
that of 143-B/LZ+scr cells (Fig. 3A,B). In contrast, in cultures of HOS/
LZ+MMP-1 cells, the number of large colonies was more than 6-fold
higher than in cultures of HOS/LZ+EV control (Fig. 3A,B).Table 1
Real time PCR for MMP-1 expression in primary osteosarcoma cells and normal human
bone cells.
MMP-1 expression Dead patients Alive patients
>2 fold of NHB 6 2
≤2 fold of NHB 3 7
NHB: normal human bone cells.
(A) were analyzed by semi-quantitative RT-PCR, and PCR products were separated
by electrophoresis in 1.2% agarose gels. MMP-1 in culture medium (B) and (C) was
analyzed on Western blots.3.3. MMP-1 promotes intratibial primary tumor growth and lung
metastasis
The in vitro characterization of malignant properties of the OS cell
lines with manipulated MMP-1 expression suggested tumor and
metastasis promoting function(s) of MMP-1 in vivo. When the
manipulated cell lines were orthotopically injected into the tibiae of
SCID mice, no differences in frequency of primary tumor formation
were observed. However, intratibial injection of 143-B/LZ+scr control
*HOS/LZ
+MMP-1
HOS/LZ
+EV
143-B/LZ
+153
143-B/LZ
+scr
*
A
B
Fig. 2. MMP-1 enhances adhesion of 143-B/LZ and HOS/LZ OS cells to collagen type I.
(A) Adhesion of indicated 143-B/LZ (left panel) and HOS/LZ (right panel) derived
cells to collagen type I. The number of adhering 143-B/LZ+scr (left panel) or HOS/
LZ+EV (right panel) control cells was set to 100%. The results are the mean±SEM
of four independent experiments. * P valueb0.05. (B) Representative images of cell ad-
hesion experiments of indicated cell lines. Bar: 50 μm.
A
HOS/LZ
+MMP-1
HOS/LZ
+EV
143-B/LZ
+153
143-B/LZ
+scr
B
*
*
Fig. 3. MMP-1 enhances anchorage-independent growth of 143-B/LZ and HOS/LZ OS
cells. (A) Anchorage independent growth of indicated 143-B/LZ (left panel) and HOS/
LZ (right panel) derived cells. The results are the mean±SEM of four independent ex-
periments. * P valueb0.05. (B) Representative images of anchorage independent
growth of indicated cell lines. Bar: 500 μm.
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after tumor cell injection, when none of the animals injected with
143-B/LZ+153 cells showed any signs of intratibial primary tumors
(not shown). Twenty days after tumor cell injection the mice of both
groups were sacriﬁced. The mice of the 143-B/LZ+scr control group
presented primary tumors with a mean volume of 247±48 mm3
(Fig. 4B) and extensive osteolytic destruction of the tibia (Fig. 4A, left
panel). In contrast, the group of mice injected with 143-B/LZ+153
cells developed much smaller primary tumors with a mean volume of
31±12 mm3 (P valueb0.05) (Fig. 4B), and osteolysis was much less
extensive compared with the mice injected with the 143-B/LZ+scr
control cells (Fig. 4A).
Lung metastasis formation was also analyzed after sacriﬁcing the
mice on day 20. Micrometastases (diameterb0.1 mm) were found on
the lungs of the 143-B/LZ+scr group at a mean number of 330±117
micrometastases per lung, which was signiﬁcantly (P valueb0.05)
higher than that (45±14.7) detected in the group injected with
143-B/LZ+153 cells (Fig. 5A,B). The number of macrometastases
(diameter>0.1 mm) was also signiﬁcantly (P valueb0.05) higher inB
A
143-B/LZ+scr 143-B/LZ+153
Fig. 4. shRNA-mediated MMP-1 knockdown in 143-B/LZ cells reduces intratibial pri-
mary tumor growth. (A) Representative X-ray images of legs from mice injected with
143-B/LZ+scr cells (left panels) or 143-B/LZ+153 cells (right panels) 20 days after
tumor cell injection showing the hindlimbs (top panels) and the leg injected with
tumor cells at a higher magniﬁcation (bottom panels). Arrows indicate osteolytic le-
sion areas. (B) Primary tumor growth over time in mice intratibially injected with
143-B/LZ+scr cells (■) (ﬁve mice) or with 143-B/LZ+153 cells (●) (eight mice).
Data are the mean±SEM calculated tumor volumes at indicated time points. * P
valueb0.05.
AB
143-B/LZ+scr 143-B/LZ+153
* *
Fig. 5. shRNA-mediated knockdown of MMP-1 in 143-B/LZ OS cells reduces lung
metastases formation. (A) Number of lung micrometastases (left panel) and
macrometastases (right panel) in mice injected with 143-B/LZ+scr (ﬁve mice) or
143-B/LZ+153 (eight mice) cells. Data are shown as the mean±SEM of at least 5
animals. * P valueb0.05. (B) Representative images show metastases on X-Gal stained
lungs of mice injected with 143-B/LZ+scr cells or with 143-B/LZ+153 cells 20 days
after tumor cell injection. Bar: 50 μm.
B
A
HOS/LZ+EV HOS/LZ+MMP-1
Fig. 6. MMP-1 overexpression of HOS/LZ cells induces intratibial primary tumor
growth. (A) Representative X-ray images of legs from mice injected with HOS/
LZ+EV cells (left panels) or HOS/LZ+MMP-1 cells (right panels) 60 days after
tumor cell injection showing the hindlimbs (top panels) and the leg injected with
tumor cells at a higher magniﬁcation (bottom panels). Arrows indicate osteolytic
lesion areas. (B) Primary tumor growth over time in mice intratibially injected with
HOS/LZ+EV cells (●) (eight mice) or HOS/LZ+MMP-1 cells (■) (seven mice). Data
are the mean±SEM calculated tumor volume at indicated time points. * P valueb0.05.
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the group injected with 143-B/LZ+153 cells (2.6±1.5) (Fig. 5A,B).
These results prompted us to investigate the properties of HOS/
LZ+MMP-1 cells in vivo for tumor and metastasis formation,
although it has been shown previously that non-manipulated HOS
cells orthotopically injected into nude mice formed neither primary
tumors nor metastases [30]. This observation was conﬁrmed in the
present study. The group of mice injected with HOS/LZ+EV control
cells developed no radiologically detectable primary tumors (Fig. 6A,
left panel). In contrast, injection of HOS/LZ+MMP-1 cells resulted in
radiologically detectable primary tumors after 6 weeks (not shown)
and X-ray images showed massive osteolytic destruction of the tibiae
at the end of the study on day 60 (Fig. 6A, right panel). Tumor growth
in the HOS/LZ+MMP-1 group was measurable 35 days after cell
injection and the average tumor volume was 155±66 mm3 at the
end of the study (Fig. 6B). On day 41 and later the mean calculated
volume of the tumors was signiﬁcantly (P valueb0.05) larger than
that of the HOS/LZ+EV-injected mice, which showed no measurable
difference between the mean calculated volume of both legs (Fig. 6B).
Sixty days after tumor cell injection the experiment was terminated
and the animals of both groups were therefore sacriﬁced. Mice injected
with HOS/LZ+MMP-1 cells had a mean number of 249±94.5
micrometastases (diameterb0.1 mm) per lung (Fig. 7A,B) but no
macrometastases (diameter>0.1 mm). In contrast and as expected,
the lungs of HOS/LZ+EV control mice with no detectable primary
tumors were free of metastases (Fig. 7A,B).
4. Discussion
Several members of the large family of MMPs are known to be
involved in the complex processes of metastasis including cell prolif-
eration, tissue remodeling, cell migration and invasion. However,
only a small group of proteases including MMP-1, -8, -13, and -14 is
able to cleave native ﬁbrillar collagen type I, the predominant ECMprotein in bone. Proteolysis of the bone ECM is a prerequisite for
primary tumor growth and metastasis formation in OS. Recently, im-
portant markers for metastatic spreading of breast cancer cells to the
lung and to the bone were identiﬁed [15,31,32]. Interestingly, MMP-1
belongs to both marker groups mediating metastasis in different or-
gans such as bone and lung.
In the present study, the role of MMP-1 in OS tumor growth and
metastasis was investigated in vitro and in vivo. In normal human
bone cells, MMP-1 mRNA expression was low or non-detectable by
RT-PCR. In contrast, robust MMP-1 expression was detected in prima-
ry OS cells and to an even higher level in the well-established highly
metastatic human 143-B OS cell line. Also Kimura et al. found a strong
MMP-1 expression in 143-B cells when they compared gene expres-
sion proﬁles of 143-B cells with those of the related MNNG/HOS
cells [33]. The observed co-expression of MMP1 and MMP-13 in the
absence of MMP-8 (Fig. 1) suggested a synergistic function, which
was also reported for giant cell tumor of bone, a primary osteolytic
bone tumor [16]. However, the highly metastatic 143-B OS tumor
A B
HOS/LZ+EV HOS/LZ+MMP-1
Fig. 7. MMP-1 overexpression in HOS/LZ cells mediates lung metastases formation. (A) Number of lung metastases in mice injected with HOS/LZ+EV (eight mice) or HOS/
LZ+MMP-1 (seven mice) cells. Data are the mean±SEM of at least 7 animals. (B) Representative images of X-Gal stained lungs from mice injected with HOS/LZ+EV cells or
HOS/LZ+MMP-1 cells 60 days after tumor cell injection. Bar: 50 μm.
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both proteases are produced by surrounding stromal cells [16].
Remarkably, both cell types contribute to the formation of primary
tumors through the degradation of type I collagen.
Cell adhesion to collagen type I and anchorage independent colo-
ny formation assays were performed to characterize in vitro the
malignant potential of the OS cell lines with manipulated MMP-1
expression. Increased adhesion of tumor cells to collagen type I as
found for the OS cells with high MMP-1 expression may reduce cell
mobility, but it also brings the tumor cells in a more stable contact
with the collagen of the ECM and the blood vessels for destruction.
Both processes are necessary for the escape of the tumor cells from
the primary tumor region. Increased soft agar colony formation of
the analyzed OS cell lines was observed in an MMP-1 dependent
manner (Fig. 3A,B). Proteolytic activation by MMP-1 of cell surface
receptors or MMP1 dependent processing of ECM associated growth
factors required for anchorage independent growth may be involved
in colony forming processes. These results are in line with the recent-
ly reported MMP-1 enhanced invasion of collagen type I matrices by
OS cells [33,34], or with MMP-1 mediated collagen matrix degra-
dation by breast cancer cells [35,36].
An earlier study reported that orthotopic injection of HOS cells
into the tibia of athymic mice revealed neither primary tumors nor
metastases [30]. This was conﬁrmed in the present study with our
lacZ-transduced control cells (HOS/LZ+EV). In contrast, intratibial
injection of HOS cells overexpressing only MMP-1 (HOS/LZ+
MMP-1) resulted in the growth of large primary tumors with remark-
able osteolysis and metastasis to the lung within 60 days. The
destruction of the bone ECM around the primary tumor is one of
the ﬁrst critical events for primary tumor growth and metastatic
spreading to distant organs, in OS mainly to the lung [37]. Apparently,
the low levels of endogenously expressed MMP-1 in the parental
HOS cells are insufﬁcient to induce tumor growth and metastasis.
However, when MMP-1 expression was up-regulated by stable
transduction with MMP-1 encoding cDNA, HOS cells became tumor-
igenic, which strongly indicated a critical role of this protease in OS
primary tumor formation.
This was further supported by the observation of delayed develop-
ment of primary tumors derived from the highly tumorigenic 143-B
cells after shRNA mediated downregulation of MMP-1. However,
143-B/LZ+scr cell-derived primary tumors were still growing faster
and became detectable 20 days earlier than those derived fromHOS/LZ+MMP1 cells despite the fact that both cell lines expressed
comparable levels of MMP-1 protein in vitro. MMP-1 is likely acting
in concert with other proteases, secreted either by tumor cells or
the surrounding stroma cells that facilitate primary tumor formation
in the bone. One of these proteases, cathepsin K, has been described
recently as a marker for OS metastasis [22]. Primary tumor formation
may also be supported by inhibitors of osteoblast activity or acti-
vators of osteoclast activity, resulting in an imbalance between bone
formation and bone resorption [38]. Nemeth et al. [39] postulated
that metastatic prostate cancer cells, similar to osteoblasts, enhance
osteoclastic bone resorption. Activation or inhibition of osteoblasts
or osteoclasts can be mediated by direct contact of the tumor cells
with the surrounding stroma cells or by soluble factors [40].
Micrometastases developed in the lungs of mice after intratibial
injection of HOS cells overexpressing MMP-1. Conversely, 143-B
cells with MMP-1 expression downregulated by shRNA generated
fewer lung micro- and macrometastases compared to control cells,
similar to the results recently published for non lacZ-tagged 143-B
cells [34]. Our results support the hypothesis that MMP-1 is not
only involved in primary tumor growth, but also assists the formation
of lung metastases in our OS models. Interestingly, the metastases
found in mice injected with 143-B cells with downregulated MMP-1
expression were still larger than those found in animals injected
with HOS cells overexpressing MMP-1, even though the time period
until analysis was 3-times longer in the experiment with the
MMP1-transduced HOS cells (60 instead of 20 days). This may be
attributable to the slower primary tumor growth of the HOS/LZ+
MMP-1 compared to the 143B/LZ cells and, consequently, delayed
metastatic spread. However, it is also conceivable that factors
required for the outgrowth of micrometastases in the lung are lack-
ing. Collectively, these data indicate that the incidence and progres-
sion of HOS lung metastases are dependent on MMP-1 expression
and also regulated by other factors differentially expressed in the
HOS and 143-B cells, which remain to be identiﬁed. In conclusion,
the results obtained with the mouse models presented here suggest
that in OS, MMP-1 is an important factor involved in primary tumor
growth and lung metastasis.Competing interests
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